Compare CLDX & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | PRVA |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 1995 | 2021 |
| Metric | CLDX | PRVA |
|---|---|---|
| Price | $42.66 | $21.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $46.60 | $31.17 |
| AVG Volume (30 Days) | 963.5K | ★ 1.3M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.64 |
| EPS | N/A | ★ 0.09 |
| Revenue | $12,743,000.00 | ★ $2,122,842,000.00 |
| Revenue This Year | $111.39 | $18.19 |
| Revenue Next Year | $235.85 | $10.72 |
| P/E Ratio | ★ N/A | $244.44 |
| Revenue Growth | ★ 87.78 | 22.26 |
| 52 Week Low | $20.37 | $19.53 |
| 52 Week High | $45.14 | $28.82 |
| Indicator | CLDX | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 63.24 | 30.59 |
| Support Level | $28.51 | $21.20 |
| Resistance Level | N/A | $24.65 |
| Average True Range (ATR) | 1.71 | 0.81 |
| MACD | 0.24 | -0.22 |
| Stochastic Oscillator | 72.23 | 36.08 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.